Skip to main content
. 2023 Nov 16;29(12):3044–3049. doi: 10.1038/s41591-023-02625-9

Table 2.

Participant characteristics per phase

Variable Initial pilot (n = 3,746) Extended pilot (n = 9,112) Live use (n = 15,953)
Age (continuous, years), mean (s.d.) 58.2 (11.0) 58.2 (10.7) 58.6 (10.5)
Age group, n (%)
≤35 years 0 (0.0%) 0 (0.0%) 0 (0.0%)
36–45 years 518 (13.8%) 1,149 (12.6%) 1,583 (9.9%)
46–55 years 1,218 (32.5%) 2,998 (32.9%) 5,420 (34.0%)
56–65 years 940 (25.1%) 2,493 (27.4%) 4,699 (29.5%)
66–75 years 806 (21.5%) 1,902 (20.9%) 3,196 (20.0%)
>75 years 264 (7.0%) 570 (6.3%) 1,055 (6.6%)
Family historya, n (%)
No 3,620 (96.6%) 8,838 (97.0%) 15,338 (96.1%)
Yes 126 (3.4%) 274 (3.0%) 615 (3.9%)
Tábar classification of parenchymal patternsb, n (%)
1 1,506 (40.2%) 3,950 (43.3%) 7,468 (46.8%)
2 729 (19.5%) 1,697 (18.6%) 2,921 (18.3%)
3 336 (9.0%) 679 (7.5%) 465 (2.9%)
4 365 (9.7%) 848 (9.3%) 1,423 (8.9%)
5 114 (3.0%) 246 (2.7%) 310 (1.9%)
Missing 696 (18.6%) 1,692 (18.6%) 3,366 (21.1%)

aFamily history of cancer = ‘yes’ if at least two first-degree female family members have been diagnosed with breast cancer.

bA Tabár classification17 of 4 or 5 correlating with high density (BI-RADS (breast imaging and reporting data system) breast density class C or D).